Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|October 25, 2007
Expression of BORIS in melanoma: lack of association with MAGE-A1 activationOlga Kholmanskikh, Axelle Loriot, Francis Brasseur, et al.
Cancer Cell|June 11, 2024
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug developmentSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Olga Kholmanskikh Van Criekingen, Simone Koole, et al.
International Journal of Cancer|January 26, 2010
Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigensOlga Kholmanskikh, Nicolas van Baren, Francis Brasseur, et al.
Nucleic Acids Research|August 19, 2004
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcriptionSandra Laduron, Rachel Deplus, Sifang Zhou, et al.
Clinical Pharmacology and Therapeutics|June 20, 2020
Can a Multistakeholder Prioritization Structure Support Regulatory Decision Making? A Review of Pediatric Oncology Strategy Forums Reflecting on Challenges and Opportunities of this ConceptDominik Karres, Giovanni Lesa, Franca Ligas, et al.
The Oncologist|April 28, 2020
EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell LymphomaIrene Papadouli, Jan Mueller-Berghaus, Claire Beuneu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2024
Empowering effective biomarker-driven precision oncology: A call to actionMark Lawler, Peter Keeling, Olga Kholmanskikh, et al.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Eclinicalmedicine|October 10, 2024
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtableChristina Yap, Olalekan Lee Aiyegbusi, Emily Alger, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug AdministrationAndrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
Pageof 2